Clinical Trial Update: Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing veliparib plus whole-brain radiation therapy to placebo plus whole-brain radiation therapy in adults with brain metastases from non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Veliparib (veliparib)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Brain Metastases From Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-02-14